Erratum: Gadd153 and NF-κB Crosstalk Regulates 27-Hydroxycholesterol-Induced Increase in BACE1 and β-Amyloid Production in Human Neuroblastoma SH-SY5Y Cells (PLoS ONE (2013) 8: 8 (e70773) DOI: 10.1371/journal.pone.0070773);Gadd153 and NF-κB Crosstalk Regulates 27-Hydroxycholesterol-Induced Increase in BACE1 and β-Amyloid Production in Human Neuroblastoma SH-SY5Y Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Marwarha, Gurdeep ^a   Raza, Shaneabbas ^a   Prasanthi, Jaya R P ^a   Ghribi, Othman ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

26 HYDROXYCHOLESTEROL; AMYLOID BETA PROTEIN; BETA SECRETASE 1; BIOLOGICAL MARKER; CENTRAL NERVOUS SYSTEM AGENTS; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SC 514; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN SH SY5Y; CONTROLLED STUDY; DNA DAMAGE; DRUG ACTIVITY; ENDOPLASMIC RETICULUM STRESS; GADD153 GENE; GENE; GENE SILENCING; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIPID OXIDATION; MALE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING;

MUS MUSCULUS;

EID: 84881258722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0307676     Document Type: Erratum

References (58)

1. Hardy J, Allsop D, (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12: 383-388.
2. Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ, (1993) beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268: 3021-3024.
3. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741.
4. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC, (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59: 1381-1389.
5. Tyler SJ, Dawbarn D, Wilcock GK, Allen S J, (2002) alpha- and beta-secretase: profound changes in Alzheimer's disease. Biochem Biophys Res Commun 299: 373-376.
6. Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G, (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann Neurol 51: 783-786.
7. Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, et al. (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A 105: 6415-6420.
8. Chadwick W, Mitchell N, Martin B, Maudsley S, (2012) Therapeutic targeting of the endoplasmic reticulum in Alzheimer's disease. Curr Alzheimer Res 9: 110-9.
9. Stutzmann GE, Mattson MP, (2011) Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease. Pharmacol Rev 63: 700-27.
10. Ghribi O, (2006) The role of the endoplasmic reticulum in the accumulation of beta-amyloid peptide in Alzheimer's disease. Curr Mol Med 6: 119-133.
11. Park SH, Choi HJ, Yang H, Do KH, Kim J, et al. (2010) Endoplasmic reticulum stress-activated C/EBP homologous protein enhances nuclear factor-kappaB signals via repression of peroxisome proliferator-activated receptor gamma. J Biol Chem 285: 35330-35339.
12. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C, (1997) Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A 94: 2642-2647.
13. Chen CH, Zhou W, Liu S, Deng Y, Cai F, et al. (2011) Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Int J Neuropsy Pharmacol 1-14.
14. Boissiere F, Hunot S, Faucheux B, Duyckaerts C, Hauw JJ, et al. (1997) Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease. Neuroreport 8: 2849-2852.
15. Lukiw WJ, Bazan NG, (1998) Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J Neurosci Res 53: 583-592.
16. Marwarha G, Dasari B, Prasanthi JR, Schommer J, Ghribi O, (2010) Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. J Alzheimers Dis 19: 1007-1019.
17. Prasanthi JRP, Huls A, Thomasson S, Thompson A, Schommer E, et al. (2009) Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol Neurodegener 4, 1.
18. Shafaati M, Marutle A, Pettersson H, Lovgren-Sandblom A, Olin M, et al. (2011) Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation. J Lipid Res 52, 1004-1010.
19. Dasari B, Prasanthi JRP, Marwarha G, Singh BB, Ghribi O, (2011) Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina. BMC Ophthalmol 11: 65-77.
20. Marwarha G, Dasari B, Ghribi O, (2012) Endoplasmic reticulum stress-induced CHOP activation mediates the down-regulation of leptin in human neuroblastoma SH-SY5Y cells treated with the oxysterol 27-hydroxycholesterol. Cell Signal 24: 484-92.
21. Bories C, Guitton MJ, Julien C, Tremblay C, Vandal M, et al. (2012) Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer's disease. PLoS One 7: e46111.
22. Hamilton LK, Aumont A, Julien C, Vadnais A, Calon F, et al. (2010) Widespread deficits in adult neurogenesis precede plaque and tangle formation in the 3xTg mouse model of Alzheimer's disease. Eur J Neurosci 32: 905-20.
23. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, et al. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39: 409-421.
24. Shih VF, Tsui R, Caldwell A, Hoffmann A, (2011) A single NFkappaB system for both canonical and non-canonical signaling. Cell Res 21: 86-102.
25. Baeuerle PA, Baltimore D, (1988) I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242: 540-546.
26. Beg AA, Baldwin AS Jr, (1993) The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev 7: 2064-2070.
27. Baxter A, Brough S, Cooper A, Floettmann E, Foster S, et al. (2004) Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors. Bioorg Med Chem Lett 14: 2817-2822.
28. Winton MJ, Lee EB, Sun E, Wong MM, Leight S, et al. (2011) Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration. J Neurosci 31: 7691-9.
29. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U, (1995) Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488.
30. Chen Z J, Parent L, Maniatis T, (1996) Site-specific phosphorylation of IkBα by a novel ubiquitination-dependent protein kinase activity. Cell 84: 853-862.
31. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M, (1997) The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91: 243-252.
32. Karin M (1999) How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18, 6867-6874.
33. Johnson LN, Noble ME, Owen DJ, (1996) Active and inactive protein kinases: structural basis for regulation. Cell 85: 149-158.
34. Mielke MM, Haughey NJ, Ratnam Bandaru VV, Schech S, Carrick R, et al. (2010) Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers Dement 6: 378-85.
35. Mielke MM, Haughey NJ, Bandaru VV, Weinberg DD, Darby E, et al. (2011) Plasma Sphingomyelins are Associated with Cognitive Progression in Alzheimer's Disease. J Alzheimers Dis 27: 259-69.
36. Han X, Rozen S, Boyle SH, Hellegers C, Cheng H, et al. (2011) Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One 6: e21643.
37. Haughey NJ, Bandaru VV, Bae M, Mattson MP, (2010) Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. Biochim Biophys Acta1801: 878-86.
38. Bazan NG, Molina MF, Gordon WC, (2011) Docosahexaenoic Acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr 31: 321-51.
39. Kumar A, Bullard RL, Patel P, Paslay LC, Singh D, et al. (2011) Non-esterified fatty acids generate distinct low-molecular weight amyloid-β (Aβ42) oligomers along pathway different from fibril formation. PLoS One 6: e18759.
40. Prasanthi JRP, Larson T, Schommer J, Ghribi O, (2011) Silencing GADD153/CHOP Gene Expression Protects Against Alzheimer's Disease-Like Pathology Induced by 27-Hydroxycholesterol in Rabbit Hippocampus. PLoS ONE 6: e26420.
41. Sun A, Koelsch G, Tang J, Bing G, (2002) Localization of beta-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls. Exp Neurol 175: 10-22.
42. Preece P, Virley DJ, Costandi M, Coombes R, Moss SJ, et al. (2003) Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease. Brain Res. Mol Brain Res 116: 155-158.
43. Leuba G, Wernli G, Vernay A, Kraftsik R, Mohajeri MH, et al. (2005) Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease. Dement. Geriatr Cogn Disord 19: 171-183.
44. Yang LB, Lindholm K, Yan R, Citron M, Xia W, et al. (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9: 3-4.
45. Li Q, Sudhof TC, (2004) Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1. J Biol Chem 279: 10542-10550.
46. Harada H, Tamaoka A, Ishii K, Shoji S, Kametaka S, et al. (2006) Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains. Neurosci Res 54: 24-29.
47. Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, et al. (2007) Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Neurosci 27: 3639-3649.
48. Zhang XM, Cai Y, Xiong K, Cai H, Luo XG, et al. (2009) Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur J Neurosci 30: 2271-2283.
49. Rossner S, Sastre M, Bourne K, Lichtenthaler SF, (2006) Transcriptional and translational regulation of BACE1 expression-implications for Alzheimer's disease. Prog Neurobiol 79: 95-111.
50. Terai K, Matsuo A, McGeer PL, (1996) Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res 735: 159-168.
51. Ferrer I, Marti E, Lopez E, Tortosa A, (1998) NF-kB immunoreactivity is observed in association with beta A4 diffuse plaques in patients with Alzheimer's disease. Neuropathol Appl Neurobiol 24: 271-277.
52. Oyadomari S, Mori M, (2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11: 381-9.
53. Milhavet O, Martindale JL, Camandola S, Chan SL, Gary DS, et al. (2002) Involvement of Gadd153 in the pathogenic action of presenilin-1 mutations. J Neurochem 83: 673-681.
54. Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, et al. (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 10: 279-288.
55. Sun X, He G, Qing H, Zhou W, Dobie F, et al. (2006) Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A 103: 18727-18732.
56. Zhang X, Zhou K, Wang R, Cui J, Lipton SA, et al. (2007) Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem 282: 10873-10880.
57. O'Connor T, Sadleir KR, Maus E, Velliquette RA, Zhao J, et al. (2008) Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 60: 988-1009.
58. Cole SL, Vassar R, (2008) The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. J Biol Chem 283: 29621-29625.